IGF1 and prostate cancer: Bufadienolide, a traditional Chinese drug Chan’Su-derived cardiac glycoside, caused G1 arrest of breast and prostate cancer cells by inhibiting insulin-like growth factor-I (IGF1)-activated phosphorylation of mTOR, S6K1, and 4EBP1 [476].